Showing 19,901 - 19,920 results of 31,755 for search '(( a step decrease ) OR ( 50 ((nn decrease) OR (((a decrease) OR (mean decrease)))) ))', query time: 0.86s Refine Results
  1. 19901

    The effects of purmorphamine and Msi1 knockdown on p21<sup>CIP1,WAF1</sup> and c-Myc expression. by In-Sun Hong (284033)

    Published 2013
    “…Purmorphamine treatment decreased and increased the expression of p21<sup>CIP1,WAF1</sup> (<b>A</b>) and c-Myc (<b>B</b>), respectively. …”
  2. 19902

    Validation and predictive accuracy of the cerebrovascular model, by Hadi Esfandi (21387211)

    Published 2025
    “…<p>(a-f) dependency of blood flow in capillaries on the cortical depth and ABNP values: (a) mean and standard deviation of blood flow in Cap1 segments for various ABNP values, (b) layer-specific average blood flow in capillaries across the entire monophasic flat autoregulation range, (c) indicates that the superficial layers have a more nonuniform hemodynamic distribution in capillaries, (d) mean capillary blood flow across different vascular layers at physiological ABNP values (50-70 mmHg), (e) WT changes in superficial PA segments are more significant than in deeper segments across the autoregulation range. …”
  3. 19903
  4. 19904
  5. 19905
  6. 19906
  7. 19907
  8. 19908
  9. 19909
  10. 19910

    Astilbin exerts anti-hypersensitivity by regulating metabolic demand and neuronal activity in rodent model of neuropathic pain by Qiru Wang (12260453)

    Published 2024
    “…</p> <p>In experiments conducted on neuropathic rats, both systemic and intrathecal administration of astilbin, an essential constituent, exhibited a noteworthy and dose-dependently decrease in chronic and acute pain behaviours. …”
  11. 19911
  12. 19912

    Tubulin-Destabilizing Agent BPR0L075 Induces Vascular-Disruption in Human Breast Cancer Mammary Fat Pad Xenografts by Li Liu (75607)

    Published 2012
    “…The current study evaluated the vascular-disrupting activity of BPR0L075 in human breast cancer mammary fat pad xenografts using dynamic bioluminescence imaging. A single dose of BPR0L075 (50 mg/kg, intraperitoneally (i.p.)) induced rapid, temporary tumor vascular shutdown (at 2, 4, and 6 hours); evidenced by rapid and reproducible decrease of light emission from luciferase-expressing orthotopic MCF7 and MDA-MB-231 breast tumors after administration of luciferin substrate. …”
  13. 19913
  14. 19914
  15. 19915
  16. 19916
  17. 19917
  18. 19918
  19. 19919
  20. 19920